From presumed metastasis to infection: coccidioidomycosis mimicking metastatic gastroesophageal adenocarcinoma

Wilfor Diaz Fernandez; Cadman Leggett

doi:10.47892/rgp.2026.463.2229

Autores/as

Wilfor Diaz Fernandez Mayo Clinic, Rochester, Minnesota, USA https://orcid.org/0000-0003-2217-790X
Cadman Leggett Mayo Clinic, Rochester, Minnesota, USA https://orcid.org/0000-0002-0495-3795

DOI:

https://doi.org/10.47892/rgp.2026.463.2229

Palabras clave:

Coccidioidomycosis, Lymphadenitis, Esophagogastric Junction, Neoplasm Staging, Lymphadenopathy

Resumen

Early gastroesophageal junction (GEJ) cancer commonly presents without distant disease. The development of locoregional lymphadenopathy and acute pulmonary embolism raises concern for metastatic disease and may lead to inappropriate upstaging if not properly investigated. We present a 51-year-old immunocompetent Hispanic man with newly diagnosed T1a GEJ adenocarcinoma who developed FDG-avid mediastinal lymphadenopathy and an incidental subsegmental pulmonary embolism on staging computed tomography. Histological sampling via endobronchial ultrasound-guided fine needle aspiration revealed granulomatous inflammation without malignancy. Further workup confirmed an acute Coccidioides lymphadenitis. The patient was successfully treated with fluconazole 400 mg daily for three months, with complete radiological and endoscopic resolution. This case underscores the critical importance of histological confirmation of lymphadenopathy before attributing it to metastatic disease in early-stage GEJ cancer. Failure to consider infectious etiologies, particularly coccidioidomycosis in endemic areas or in patients with travel history, may result in unnecessary upstaging, inappropriate treatment escalation, and avoidable harm.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Gamboa AM, Kim S, Force SD, Staley CA, Woods KE, Kooby DA, et al. Treatment allocation in patients with early-stage esophageal adenocarcinoma: prevalence and predictors of lymph node involvement. Cancer. 2016;122(14):2150-2157. doi: 10.1002/cncr.30040.

Leers JM, DeMeester SR, Oezcelik A, Klipfel N, Ayazi S, Abate E, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma: a retrospective review of esophagectomy specimens. Ann Surg. 2011;253(2):271-278. doi: 10.1097/SLA.0b013e3181fbad42.

Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg. 2000;232(6):733-742. doi: 10.1097/00000658- 200012000-00002.

Nguyen CL, Tovmassian D, Isaacs A, Falk GL. Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a metaanalysis. Dis Esophagus. 2024;37(6):doae012. doi: 10.1093/ dote/doae012.

Newton AD, Predina JD, Xia L, Roses RE, Karakousis GC, Dempsey DT, et al. Surgical management of early-stage esophageal adenocarcinoma based on lymph node metastasis risk. Ann Surg Oncol. 2018;25(1):318-325. doi: 10.1245/ s10434-017-6238-z.

Quint LE, Bogot NR. Staging esophageal cancer. Cancer Imaging. 2008;8(Spec Iss A):S33-S42. doi: 10.1102/1470- 7330.2008.9007.

Asano S. Granulomatous lymphadenitis. J Clin Exp Hematop. 2012;52(1):1-16. doi: 10.3960/jslrt.52.1.

Johnson RH, Sharma R, Kuran R, Fong I, Heidari A. Coccidioidomycosis: a review. J Investig Med. 2021;69(2):316- 323. doi: 10.1136/jim-2020-001655.

Guo X, Ruan Q, Jin J, Zheng J, Shao L, Li N, et al. Disseminated coccidioidomycosis in immunocompetent patients in nonendemic areas: a case series and literature review. Eur J Clin Microbiol Infect Dis. 2022;41(6):925-939. doi: 10.1007/s10096- 022-04447-y.

Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann N Y Acad Sci. 2007;1111:411- 421. doi: 10.1196/annals.1406.010.

Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, et al. Coccidioidomycosis involving lungs and skin: a mimicker of metastatic disease. Am J Dermatopathol. 2018;40(3):e41-e43. doi: 10.1097/DAD.0000000000000986.

Johnson RH, Sharma R, Kuran R, Fong I, Heidari A. Coccidioidomycosis: a review. J Investig Med. 2021;69(2):316- 323. doi: 10.1136/jim-2020-001655.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112-e146. doi: 10.1093/cid/ciw360.

Nassif EF, Maloney N, Conley AP, Keung EZ. Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report. Front Med (Lausanne). 2021;8:715939. doi: 10.3389/ fmed.2021.715939.

Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, et al. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease. Am J Dermatopathol. 2018;40(3):e41-e43. doi: 10.1097/DAD.0000000000000986.

Stieglitz E, Hsiang MS, Simko JP, Hirose S, Goldsby RE. Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma. J Pediatr Hematol Oncol. 2014;36(1):e57-e60. doi: 10.1097/MPH.0b013e318286d4fd.

Smith MA, Anderson AE, Kostroff K. An unusual case of coccidioidomycosis. J Clin Microbiol. 1994;32(4):1063-1064. doi: 10.1128/jcm.32.4.1063-1064.1994.

Takanami K, Kaneta T, Yamada T, Kinomura S, Yamada S, Fukuda H, et al. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports. Clin Nucl Med. 2008;33(4):258- 261. doi: 10.1097/RLU.0b013e3181662fda.

Perko R, Messinger Y, Moertel C. Pseudometastasis secondary to histoplasmosis infection: false-positive PET/CT findings. Pediatr Blood Cancer. 2010;54(4):621-3. doi: 10.1002/ pbc.22363.

Mackie GC, Pohlen JM. Mediastinal histoplasmosis: F-18 FDG PET and CT findings simulating malignant disease. Clin Nucl Med. 2005;30(9):633-635. doi: 10.1097/01. rlu.0000174208.51462.27.

Zhang X, Hu Y, Tian C, Wei Q, Bian Y. Disseminated cryptococcosis mimicking malignant lymphoma on 18F-FDG PET/CT: A case report. Medicine (Baltimore). 2022;101(43):e31374. doi: 10.1097/MD.0000000000031374.

Tetzlaff ED, Cheng JD, Ajani JA. Thromboembolism in gastrointestinal cancers. Gastrointest Cancer Res. 2008;2(6):267-272.

Hanna NM, Williams E, Kong W, Fundytus A, Booth CM, Patel SV, et al. Incidence, timing, and outcomes of venous thromboembolism in patients undergoing surgery for esophagogastric cancer: a population-based cohort study. Ann Surg Oncol. 2022. doi: 10.1245/s10434-022-11520-5.

Papaxoinis G, Kamposioras K, Germetaki T, Weaver JMJ, Stamatopoulou S, Nasralla M, et al. Predictive factors of thromboembolic complications in patients with esophagogastric adenocarcinoma undergoing preoperative chemotherapy. Acta Oncol. 2018;57(6):790-798. doi: 10.1080/0284186X.2017.1423375.

Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, et al. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol. 2014;9(8):1202-1206. doi: 10.1097/ JTO.0000000000000222.

van Westreenen HL, Heeren PA, Jager PL, van Dullemen HM, Groen H, Plukker JT. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography. Ann Surg Oncol. 2003;10(9):1100-1105. doi: 10.1245/aso.2003.03.005.

Deppen SA, Blume JD, Kensinger CD, Morgan AM, Aldrich MC, Massion PP, et al. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. JAMA. 2014;312(12):1227-1236. doi: 10.1001/jama.2014.11488.